VC: Investing preapproval too risky

An interview with med tech VC investor Dave Eichler of Psilos explores the current venture investing landscape in the sector. He said his firm is focused on growth capital for medical device companies and no longer seeks to invest preapproval. Psilos used to invest in early-stage med tech but doesn't any longer since the risk/reward calculation wasn't making sense. The firm also focuses on technology that can lower the cost and improve the quality of healthcare. Molecular breast imaging is of particular interest to Eichler currently. More